AK
Azhar Khan Azmat Khan
About Azhar Khan Azmat Khan
Data last updated:
Azhar Khan Azmat Khan has 1 years in corporate governance. Holds Additional Director role. Currently with 1 company, including Tiraz Pharmaceutical Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Tiraz Pharmaceutical Private Limited at ₹5.2 Lakh (FY 2025).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Tiraz Pharmaceutical Private Limited U46497PN2023PTC221332 | Additional Director | 04 Jul 2025 | – | ₹5.2 Lakh (FY 2025) | Active |
Previous companies
Explore Director's current and past company associations Uncover their professional journey today!
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Azhar Khan Azmat Khan
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Azhar Khan Azmat Khan
Azhar Khan Azmat Khan has 1 years in corporate governance. Holds Additional Director role. Currently with 1 company, including Tiraz Pharmaceutical Private Limited. Engaged in General Business. Contributes to corporate operations. The largest current company by reported revenue is Tiraz Pharmaceutical Private Limited at ₹5.2 Lakh (FY 2025).
Azhar Khan Azmat Khan is associated with 1 company as Additional Director, including Tiraz Pharmaceutical Private Limited (₹5.2 Lakh).
Azhar Khan Azmat Khan has expertise in General Business.
Azhar Khan Azmat Khan has 1 years in corporate governance.
By reported revenue, the largest current company of Azhar Khan Azmat Khan is Tiraz Pharmaceutical Private Limited, with revenue of ₹5.2 Lakh (FY 2025).
Azhar Khan Azmat Khan currently holds positions at 1 company: Tiraz Pharmaceutical Private Limited (₹5.2 Lakh).